ZA200204189B - Method of treating hair loss using thyromimetic compounds. - Google Patents

Method of treating hair loss using thyromimetic compounds.

Info

Publication number
ZA200204189B
ZA200204189B ZA200204189A ZA200204189A ZA200204189B ZA 200204189 B ZA200204189 B ZA 200204189B ZA 200204189 A ZA200204189 A ZA 200204189A ZA 200204189 A ZA200204189 A ZA 200204189A ZA 200204189 B ZA200204189 B ZA 200204189B
Authority
ZA
South Africa
Prior art keywords
hair loss
treating hair
thyromimetic compounds
compounds
thyromimetic
Prior art date
Application number
ZA200204189A
Other languages
English (en)
Inventor
Chiang Yuan-Ching Phoebe
Peter Cornelius
Doherty Niall Stephen
Dow Robert Lee
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA200204189B publication Critical patent/ZA200204189B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4966Triazines or their condensed derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200204189A 2001-05-31 2002-05-27 Method of treating hair loss using thyromimetic compounds. ZA200204189B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29496201P 2001-05-31 2001-05-31

Publications (1)

Publication Number Publication Date
ZA200204189B true ZA200204189B (en) 2003-11-27

Family

ID=23135661

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200204189A ZA200204189B (en) 2001-05-31 2002-05-27 Method of treating hair loss using thyromimetic compounds.

Country Status (19)

Country Link
US (2) US20030007941A1 (xx)
EP (1) EP1262177B1 (xx)
JP (1) JP4051230B2 (xx)
KR (1) KR100523503B1 (xx)
CN (1) CN1314393C (xx)
AT (1) ATE337009T1 (xx)
AU (1) AU784806B2 (xx)
CA (1) CA2387198C (xx)
CY (1) CY1105221T1 (xx)
DE (1) DE60214080T2 (xx)
DK (1) DK1262177T3 (xx)
ES (1) ES2267945T3 (xx)
HK (1) HK1049285B (xx)
HU (1) HUP0201834A3 (xx)
IL (2) IL149843A (xx)
PL (1) PL354216A1 (xx)
PT (1) PT1262177E (xx)
TW (1) TWI278313B (xx)
ZA (1) ZA200204189B (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
WO2003099105A2 (en) * 2002-05-23 2003-12-04 Powell Michael J Diagnosis and treatment of human dormancy syndrome
US7485298B2 (en) 2002-05-23 2009-02-03 Michael Powell Diagnosis and treatment of human dormancy-related sequellae
US7622103B1 (en) * 2003-03-27 2009-11-24 Cielo Jill M Hair and scalp toxin remover composition and method of its making
KR20070120559A (ko) 2005-03-29 2007-12-24 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 새로운 모낭 생성 방법, 탈모 치료 방법 및 체모 제거 방법
US8147815B2 (en) * 2005-12-16 2012-04-03 Celmatrix Corporation Topical administration carrier composition and therapeutic formulations comprising same
RU2527948C2 (ru) 2009-04-20 2014-09-10 Мицубиси Танабе Фарма Корпорейшн Новый агонист бета рецептора тиреоидного гормона
JP2014500275A (ja) 2010-12-06 2014-01-09 フォリカ,インコーポレイテッド 禿頭症を治療するため、および毛髪の成長を促進するための方法
WO2013183678A1 (ja) * 2012-06-08 2013-12-12 大正製薬株式会社 発毛組成物
EP2695611B1 (en) 2012-08-06 2014-10-01 Dr. August Wolff GmbH & Co. KG Arzneimittel Eprotirome for use in the prevention and/or treatment of hair disorders and compositions thereof
TWI516272B (zh) 2013-06-05 2016-01-11 財團法人工業技術研究院 應用於生髮之方法及醫藥組成物
US9402876B2 (en) 2013-11-27 2016-08-02 Industrial Technology Research Institute Method and pharmaceutical composition for hair growth
CN104306168B (zh) * 2014-10-15 2017-05-24 华东师范大学 氮‑(4‑氯‑2,5‑二甲氧基苯基)‑5‑异丙基‑2‑甲氧基苯磺酰胺在促进毛发生长的应用
CN110022869A (zh) 2016-07-15 2019-07-16 巴斯德研究院 用于皮肤和/或毛发修复的5-羟色胺1b受体刺激剂
US9962444B2 (en) 2016-09-27 2018-05-08 Shane Malek Pharmacokinetically extended action topical hair growth formulation, and administration method
CN111094554A (zh) 2017-09-14 2020-05-01 国立研究开发法人理化学研究所 视网膜组织的制备方法
CN108727344A (zh) * 2018-05-14 2018-11-02 嘉兴特科罗生物科技有限公司 一种化合物及其合成方法和应用
US11766392B2 (en) * 2018-10-05 2023-09-26 Jupiter Wellness, Inc. Minoxidil adjuvant therapies
US11628132B2 (en) 2018-10-05 2023-04-18 Jupiter Wellness, Inc. Minoxidil adjuvant therapies
WO2020184720A1 (ja) 2019-03-13 2020-09-17 大日本住友製薬株式会社 移植用神経網膜の品質を評価する方法及び移植用神経網膜シート
US11091467B2 (en) 2019-05-08 2021-08-17 Aligos Therapeutics, Inc. Modulators of THR-β and methods of use thereof
CA3164404A1 (en) 2020-01-13 2021-07-22 Jingye Zhou Thyroid hormone receptor agonists and uses thereof
WO2022037617A1 (zh) * 2020-08-19 2022-02-24 成都凡诺西生物医药科技有限公司 腈代三嗪类衍生物及其制备方法和应用
JPWO2022054925A1 (xx) 2020-09-11 2022-03-17
WO2022054924A1 (ja) 2020-09-11 2022-03-17 大日本住友製薬株式会社 移植用組織のための媒体
WO2023090427A1 (ja) 2021-11-19 2023-05-25 国立研究開発法人理化学研究所 シート状網膜組織の製造方法
CN116327765A (zh) * 2023-03-27 2023-06-27 广州许愿树毛发医学科技有限公司 莲心碱类化合物作为β2-肾上腺素受体阻断剂的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU192989B (en) * 1983-08-17 1987-08-28 Wellcome Found Process for production of phisiologically active hormone preparatives
JPS61165311A (ja) * 1985-01-14 1986-07-26 Takeo Kinji 養毛化粧料
US5061798A (en) * 1985-01-18 1991-10-29 Smith Kline & French Laboratories, Ltd. Benzyl pyridyl and pyridazinyl compounds
US5284971A (en) * 1992-07-16 1994-02-08 Syntex (U.S.A.) Inc. 4-(3-cyclohexyl-4-hydroxy or-methoxy phenylsulfonyl) 3,5 dibromo phenyl acetic thyromimetic cholesterol-lowering agents
WO1994023717A1 (en) * 1993-04-20 1994-10-27 The Procter & Gamble Company Methods of using hesperetin for sebum control and treatment of acne
TW382595B (en) * 1993-10-15 2000-02-21 Merck & Co Inc Pharmaceutical composition for use in arresting and reversing androgenic alopecia
WO1998032417A1 (fr) * 1997-01-23 1998-07-30 Taisho Pharmaceutical Co., Ltd. Tonique capillaire persistant
HUP0200248A3 (en) * 1999-03-01 2002-11-28 Pfizer Prod Inc Oxamic acids and derivatives as thyroid receptor ligands, pharmaceutical compositions containing them as active ingredient and their use
CO5160290A1 (es) * 1999-03-29 2002-05-30 Novartis Ag Derivados de acido fenoxifeniloxamico sustituido .
CA2375667A1 (en) * 1999-06-01 2000-12-07 The University Of Texas Southwestern Medical Center Sulfur-containing thyroxane derivatives and their use as hair growth promotors
EP1183074A1 (en) * 1999-06-01 2002-03-06 University Of Texas Southwestern Medical Center Substituted biaryl ether compounds
CA2374263A1 (en) * 1999-06-01 2000-12-07 The University Of Texas Southwestern Medical Center Method of treating hair loss using diphenylether derivatives
EP1185232A1 (en) * 1999-06-01 2002-03-13 University Of Texas Southwestern Medical Center Method of treating hair loss using sulfonyl thyromimetic compounds
MXPA01012496A (es) * 1999-06-01 2002-07-02 Univ Texas Southwestern Med Ct Compuestos de biarilo.
ES2240017T3 (es) * 1999-09-30 2005-10-16 Pfizer Products Inc. Derivados de 6-azauracilo como ligandos de receptores tiroideos.
CA2403806A1 (en) * 2000-03-23 2002-09-20 Bayer Aktiengesellschaft Indoles for treating diseases that can be treated using thyroid hormones
AU2002223626A1 (en) * 2000-10-20 2002-04-29 Novartis Ag Combinations of a thyromimetic compound and a statin

Also Published As

Publication number Publication date
PT1262177E (pt) 2006-12-29
DE60214080D1 (de) 2006-10-05
JP4051230B2 (ja) 2008-02-20
US20080125433A1 (en) 2008-05-29
EP1262177B1 (en) 2006-08-23
AU784806B2 (en) 2006-06-29
ES2267945T3 (es) 2007-03-16
CN1389203A (zh) 2003-01-08
AU4446202A (en) 2002-12-05
EP1262177A2 (en) 2002-12-04
HU0201834D0 (xx) 2002-08-28
CA2387198A1 (en) 2002-11-30
HK1049285B (zh) 2007-08-24
PL354216A1 (en) 2002-12-02
ATE337009T1 (de) 2006-09-15
JP2002370978A (ja) 2002-12-24
CA2387198C (en) 2007-02-13
TWI278313B (en) 2007-04-11
KR100523503B1 (ko) 2005-10-26
IL149843A0 (en) 2002-11-10
DK1262177T3 (da) 2006-11-20
HUP0201834A3 (en) 2004-03-29
IL188110A0 (en) 2008-03-20
HUP0201834A2 (hu) 2003-01-28
CY1105221T1 (el) 2010-03-03
EP1262177A3 (en) 2003-09-03
US20030007941A1 (en) 2003-01-09
CN1314393C (zh) 2007-05-09
KR20020092247A (ko) 2002-12-11
HK1049285A1 (en) 2003-05-09
DE60214080T2 (de) 2007-01-04
IL149843A (en) 2008-11-26

Similar Documents

Publication Publication Date Title
HK1049285A1 (en) Method of treating hair loss using thyromimetic compounds
HK1145692A1 (zh) 人血管生成素- 的特異結合劑
EP1545587A4 (en) LACTOFERRIN COMPOSITIONS AND METHODS OF TREATING WOUNDS
BR0211251B1 (pt) composição para o tratamento de cabelo e/ou couro cabeludo.
HK1048831A1 (en) Human ctla-4 antibodies and their uses
BR0202519B1 (pt) métodos para tratamento de material de madeira e para tratamento microbicida de material de madeira.
DE60034871D1 (de) Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust
IL169701A0 (en) The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl
DE60236318D1 (de) Präparationen grampositiver bakterien zur behandlung von krankheiten mit immunfehlregulation
BR0201862A (pt) Composições e métodos para tratar ou prevenir convulsões ou ataques apoplécticos
EP1461047A4 (en) COMPOSITIONS AND METHODS FOR TREATING ANIMALS
HK1074840A1 (en) Novel dithiolopyrrolones with therapeutic activity
GB9806029D0 (en) 8a-Azalides as veterinary antimicrobial agents
DK1043028T3 (da) Phytase til forebyggelse eller behandling af mastitis
DE60137459D1 (de) Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen
AU2003290970A8 (en) Compositions and method for treating affective, painful or allergic disorders
GB0003234D0 (en) Method of treatment
AU2003249999A8 (en) 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours
ATE411739T1 (de) Verfahren und mittel zur behandlung von krebs bei hunden
AU9683401A (en) Flea peritrophin nucleic acid molecules, proteins and uses thereof
RU2001101227A (ru) Антибактериальное средство для лечения кожных заболеваний
UA33231A (uk) Спосіб добору великої рогатої худоби з прогнозованим ефектом селекції по молочності і м'ясності